leisure time -WSS

leisure time

author：focus 2025-09-30 22:05:26 - browse：17

The Dr. Gary B. and Pamela S. Williams Tower in Summa Health System's Akron Campus — Summa Health

General Catalysts’s grand vision for a venture capital-owned hospital system seamlessly blending AI and tech into everyday appointments and rewarding staff for keeping patients healthy might sound alluring. But the firm’s bold experiment is facing hurdles even before it has started as the community served by the health system it hopes to buy is pushing back.

The Health Assurance Transformation Corp., a General Catalyst entity known as HATCo, unveiled plans last month to acquire Akron safety net provider Summa Health. But since the announcement, residents and local officials have raised questions about who the deal benefits, and who gets left behind.

On Thursday, the Mayor of Akron plans to press HATCo’s chief executive, Marc Harrison, who previously led Intermountain Health, on whether his plan is a profit play or a longer-term investment in the community. At the forefront are citizens’ concerns that the deal will drive up costs, eliminate jobs, reduce the quality of care or even shutter one of just two major hospital systems in the area, about a fifth of whose patients are on Medicaid.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： In utero gene editing: an explainer

WSS

Wild otter attack leads to woman being airlifted to hospital, 2 others treated for injuries

ER docs worry over extreme heat as a 'mass casualty event'

Antivenom research: Lessons from HIV applied in search for universal antidote

Who is Magistrate Judge Moxila Upadhyaya in Trump's Jan. 6 case?

Why palliative psychiatry is worth discussing

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

hotspot

leisure time

knowledge

Bright Health sells Medicare Advantage business to Molina

TytoCare raises $49 million to build out AI

DIEP, the 'gold standard' of breast reconstruction, is under threat

'Ancient DNA,' 23andMe reveal African American ancestries

At least 13 dead in Texas as scorching temps continue

CDC: Uninsured rate hit 'record low' right as states cut Medicaid

Trump demands the U.S. pay no more for drugs than other countries … again

Attacks on the drug industry will lead to fewer breakthroughs

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

NIH study of ME/CFS points to clear biological hallmarks

explore

Alabama frozen embryo ruling has major implications for IVF clinics

A new nitrogen execution bill also undermines medical licensing

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

In utero gene editing: an explainer

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

STAT readers on older presidents, polypills, Medicare, and more

leisure time

Wikipedia

hotspot

explore